由链霉菌K07-0010产生的新异色满麝香类抗锥体虫药
摘要
通过萃取、硅胶柱色谱、十八烷基硅烷键合硅胶柱色谱以及制备高效液相色谱，从链霉菌K07．0010发酵液中分离得到两个新的异色满麝香类化合物panowamycins A和B，以及已知化合物NFAT-133、conglobatin、粉蝶霉素C系列化合物和二活菌素。
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2013年第3期234-234,共1页
Chinese Journal of Pharmaceuticals
参考文献6
-
1Tahrani AA, Piva MK, Barnett AH. Saxaglitin: a new dipeptidyl peptidase-4 inhibtor for the treat of type 2 diabetes EJ]. Adv Ther, 2009, 26(3) : 281-294.
-
2刘萍,周箐,杨小军,李劲,程立宇.治疗2型糖尿病新药——Saxagliptin[J].中国药房,2010,21(1):80-82. 被引量：6
-
3Havale SH. Medicinal chemistry approaches to the inhibition of dipeptidy peptidase-4 for the treatment of type 2 diabetes [J]. Bioorg Med Chem, 2009, 17 (5) : 1783-1802.
-
4Cao K, Samuel J, Bonacorsi JR, et al. Carbon-14 labeling of Saxaglipin (BMS-477118) [J]. J Label Compd Radiopharm, 2007, 50(13): 1224-1229.
-
5Matthew M. Process for preparing dipeptidyl IV inhibitors and intermediates therefor: WO, 2005106011 [P]. 2005-11-10. (CA 2005, 143: 458679).
-
6Berner M, Partanen R. Process for the preparation of admantane derivatives: WO, 2006128952 [P]. 2006-12-07. (CA 2006, 146: 27567).
二级参考文献11
-
1Tahrani AA, Piva MK, Bamett AH. Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes[J]. Adv Ther, 2009,26 (3) : 249.
-
2Havale SH, Pal M.Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes[J].Bioorg Med Chem, 2009, 17 ( 5 ) : 1 783.
-
3Cole N , Serradell N, Bolos J.Saxagliptin[J].Drugs of the Future, 2008,33 (7) : 577.
-
4Deacon CF,Holst JJ.Saxagliptin: a new dipeptidyl peptid- ase-4 inhibitor for the treatment of type 2 diabetes[J]~Adv Ther,2009,26(5) :488.
-
5FDA.FDA briefing terials table of contents saxagliptin [EB/OL]. http ://www.fda.gov/ohrms/dockets/ac 109/briefing/2009-4422b1-01-FDA, pdf. 2009-04-01.2009-08- 28.
-
6Fura A, Khanna A, Vyas V, et al.Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections[J].Drug Metab Dispos, 2009,37(6) : 1 164.
-
7Rosenstock J,Aquilar-Salinas C,Klein E,et al.Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes[J].Curr Med Res Opin, 2009, 25 (10) : 2 401.
-
8Defronzo RA, Hissa MN, Garber AJ, et al.The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes on metformin alone[J].Diabetes Care, 2009,32 ( 9 ) : 1 649.
-
9Chacra AR, Tan GH, Apanovitch A, et al.Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial[J].Int J Clin Pract, 2009,63 (9) : 1 395.
-
10Jadzinsky M, Pfutzner A, Paz-Pacheco E, et aI.Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial[J] .Diabetes Obes Metab, 2009,11 (6) : 611.
共引文献5
-
1余志清.抗糖尿病新药Linagliptin的临床研究进展[J].中国药房,2012,23(22):2086-2090. 被引量：1
-
2李维辉,苟佳佳,李靖柯.治疗2型糖尿病新药——利拉利汀[J].中国药房,2012,23(34):3242-3244. 被引量：1
-
3李爱娟(综述).糖尿病药物治疗新进展[J].沈阳部队医药,2012,25(6):466-470.
-
4李先喆,宗乾收,吴建一,车大庆.2-(3-羟基-1-金刚烷)-2-氧代乙酸的合成[J].中国医药工业杂志,2013,44(3):233-234. 被引量：2
-
5李爱娟,何瑞.糖尿病药物治疗的现状[J].中华老年多器官疾病杂志,2013,12(11):871-876. 被引量：1
-
1牛治刚,韩波,韩腾.双环中同时被取代的异色满类化合物合成研究[J].四川化工,2013,16(5):20-23.
-
2王进军,姜贵吉,方文龙,金景姬.7-羧基异色满并[4,3-b]喹啉衍生物的合成及其抗炎作用[J].中国医药工业杂志,1991,22(3):103-105.
-
3封喜雷.一种新型药渣挤渣车的开发研究[J].化工与医药工程,2016,37(6):55-57.
-
4王进军,欧阳杰,姜贵吉,李华.异色满并三氮杂酮化合物的合成[J].有机化学,1991,11(3):314-317. 被引量：1
-
5王进军,韩光范,姜贵吉.异苯并二氢吡喃并[3,4-b]吡啶酮衍生物的合成及其抗炎活性[J].应用化学,1991,8(1):38-41. 被引量：4
-
6朴明珠,王进军.异色满并杂环化合物的合成[J].化学试剂,1993,15(3):177-178.
-
7王进军,刘永军,姜贵吉.3,4-二氢-1 H-2-苯并吡喃衍生物的合成[J].有机化学,1991,11(2):198-203. 被引量：2
-
8郝立栋.铝料仓偏心锥体制作技术[J].中国科技期刊数据库 工业A,2015(12):287-287.
-
9孙文立,万龙茂.二段转化炉的衬里损坏及修复[J].化工设备与防腐蚀,1999,2(3):22-24.
-
10姚年善,王振华,耿建利,孙波.甲醇转化管下锥体状态分析及其剩余寿命预测[J].石油化工设计,2008,25(1):47-50.
